LSE : 0ILL.L

Laboratorios Farmaceuticos Rovi, S.A. — Earnings Estimates

$58.6 EUR

$2.3 (4.09%)

Volume
16.56K
Average Volume
11.27K
Market Capitalization
$3B
P/E Ratio
27.02
Dividend Yield
1.65%
Price Target
Year High
$79.76
Year Low
$37.14
Day High
—
Day Low
—
Payout Ratio
$0.26
Current Ratio
$2.05

Annual earnings financials

0ILL.L financial data with annual/quarterly toggle

0ILL.L GAAP EPS - Annual & Quarterly

0ILL.L Sales Revenue - Annual & Quarterly

0ILL.L Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

0ILL.L Estimated and Actual Revenue by Quarter
0ILL.L Estimated and Actual EPS by Quarter
0ILL.L Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 4 50.69M 54.42M 52.9M 45.21M 48.54M 47.18M
2026-03-31 2 45.63M 46.14M 45.89M 40.7M 41.16M 40.93M
2025-12-31 7 61.55M 62.98M 62.09M 54.89M 56.17M 55.38M
2025-09-30 3 62.16M 63.05M 62.46M 55.44M 56.24M 55.71M
2025-06-30 1 47.29M 47.29M 47.29M 42.17M 42.17M 42.17M
2025-03-31 4 43.91M 44.98M 44.69M 39.16M 40.12M 39.86M
0ILL.L Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 4 - - - 38.11M 40.92M 39.77M
2026-03-31 2 - - - 34.31M 34.69M 34.5M
2025-12-31 7 - - - 46.27M 47.34M 46.68M
2025-09-30 3 - - - 46.73M 47.4M 46.96M
2025-06-30 1 - - - 35.55M 35.55M 35.55M
2025-03-31 4 - - - 33.01M 33.81M 33.6M
0ILL.L Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 4 170.42M 182.99M 177.87M 0 0 0 0
2026-03-31 2 153.42M 155.15M 154.28M 0 0 0 0
2025-12-31 7 206.93M 211.73M 208.76M 0 0 0 0
2025-09-30 3 209M 212M 210M 0 0 0 0
2025-06-30 1 158.98M 158.98M 158.98M 0 0 0 0
2025-03-31 4 147.63M 151.22M 150.25M 0 0 0 0